Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 16, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Xylem Helps to Optimize and Control Bioprocessing and Life Sciences Applications
Wednesday, March 12, 2014
The Company’s YSI brand 2900 Series Biochemistry Analyzers have the ability to accurately and rapidly monitor and control fermentations and cell cultures.

SFU Completes Installation of Electron Microscopes from FEI
Tuesday, March 11, 2014
SFU’s new multi-million-dollar Centre for Soft Materials now offers the most advanced suite of microscopes in Western Canada.

Ultra Low Adhesion Plates for Superior 3D Spheroid Cell Culture
Tuesday, March 04, 2014
Lipidure®-Coat low adhesion plates and dishes from AMSBIO.

Irisbiosciences a New Player in 3D Cell Culture
Friday, February 14, 2014
Irisbiosciences is focused on the development, manufacturing and marketing of products for bio-/pharmaceutical research and development, namely 3D cell culture products, tissue models and human & stem cells for in-vitro experimentation.

New Article by Spinnovation Biologics’ CEO Frederic Girard
Friday, February 07, 2014
New article details NMR for Quality by Design biologics development.

Phasefocus Announces the Availability of the VL Series of Live Cell Imaging Systems
Wednesday, February 05, 2014
A family of phase microscopy systems for live cell imaging.

Virtual Microscope Images at Fingertips
Tuesday, January 28, 2014
Olympus launches its OlyVIA Mobile iPad App, an image viewer dedicated to virtual slides.

Seward Stomacher® used for hygiene monitoring and biosecurity
Monday, January 27, 2014
Sponge swab and Stomacher technique proved to be highly effective sampling combination for assessing large surface areas

Hamamatsu Introduces New Addition to the ORCA-Flash4.0 Family
Wednesday, January 15, 2014
Bigger, faster images with the exceptional new ORCA-Flash4.0 LT Gen II scientific CMOS camera.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 236
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv